WallStreetZenWallStreetZen

NASDAQ: PTCT
Ptc Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Ptc Therapeutics revenue was $806.78M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $213.2M, up 8.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PTCT annual revenue was $806.8M, with -14% growth year-over-year.

PTCT past revenue growth

How has PTCT's revenue growth performed historically?

Company
-13.97%
Industry
497.69%
Market
20.68%
PTCT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PTCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PTCT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PTCT revenue history

Current Revenue
$806.8M
Current Earnings
-$363.3M
Current Profit Margin
-45%

Be the first to know when PTCT announces revenue.

PTCT Revenue History By Year

PTCT Yearly RevenuePTCT RevenuePTCT ChangePTCT Revenue Growth
2024-12-31$806.78M-$131.04M-13.97%
2023-12-31$937.82M$239.02M+34.20%
2022-12-31$698.80M$160.21M+29.75%
2021-12-31$538.59M$157.83M+41.45%
2020-12-31$380.77M$73.79M+24.04%
2019-12-31$306.98M$42.25M+15.96%
2018-12-31$264.73M$70.34M+36.19%
2017-12-31$194.39M$111.69M+135.04%
2016-12-31$82.71M$45.94M+124.95%
2015-12-31$36.77M$11.52M+45.64%
2014-12-31$25.25M-$9.45M-27.24%
2013-12-31$34.70M$750.00k+2.21%
2012-12-31$33.95M-$71.47M-67.80%
2011-12-31$105.41MN/AN/A

1 of 1

Ptc Therapeutics Revenue FAQ

What was PTCT's revenue last quarter?

On Invalid Date, Ptc Therapeutics (NASDAQ: PTCT) reported Q4 2024 revenue of $213.17 million up 30.58% year over year. In the same quarter last year, Ptc Therapeutics's revenue was $307.06 million.

What was Ptc Therapeutics's revenue in 2024?

Ptc Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $806.78 million, a 13.97% decrease year over year.

How much does Ptc Therapeutics make in a day?

Based on Ptc Therapeutics annual revenue for the past five years, PTCT makes an average of $1,842,609.32 per day.

What was Ptc Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Ptc Therapeutics's revenue has grown -13.97% year over year. This is 511.67 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Ptc Therapeutics's revenue in the past year totaled $806.78 million.

How much does Ptc Therapeutics make in a year?

Ptc Therapeutics's revenue by year for the past five years is:
  • Ptc Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $806.78 million, a 13.97% decrease year over year.
  • Ptc Therapeutics's annual revenue for Dec 31, 2023 was $937.82 million, a 34.2% increase from 2022.
  • Ptc Therapeutics's annual revenue for 2022 was $698.80 million, a 29.75% increase from 2021.
  • Ptc Therapeutics's annual revenue for 2021 was $538.59 million, a 41.45% increase from 2020.
  • Ptc Therapeutics's annual revenue for 2020 was $380.77 million, a 24.04% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.